- Home
- MKZR vs FBIO Comparison
MKZR vs FBIO Comparison
Compare MKZR & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKZR
- FBIO
- Stock Information
- Founded
- MKZR 2012
- FBIO 2006
- Country
- MKZR United States
- FBIO United States
- Employees
- MKZR N/A
- FBIO N/A
- Industry
- MKZR
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- MKZR
- FBIO Health Care
- Exchange
- MKZR Nasdaq
- FBIO Nasdaq
- Market Cap
- MKZR 56.6M
- FBIO 39.4M
- IPO Year
- MKZR N/A
- FBIO N/A
- Fundamental
- Price
- MKZR $4.20
- FBIO $2.06
- Analyst Decision
- MKZR
- FBIO Strong Buy
- Analyst Count
- MKZR 0
- FBIO 3
- Target Price
- MKZR N/A
- FBIO $18.00
- AVG Volume (30 Days)
- MKZR 70.5K
- FBIO 711.6K
- Earning Date
- MKZR 01-01-0001
- FBIO 11-14-2024
- Dividend Yield
- MKZR 3.12%
- FBIO N/A
- EPS Growth
- MKZR N/A
- FBIO N/A
- EPS
- MKZR N/A
- FBIO N/A
- Revenue
- MKZR $17,563,335.00
- FBIO $81,501,000.00
- Revenue This Year
- MKZR N/A
- FBIO N/A
- Revenue Next Year
- MKZR N/A
- FBIO $128.63
- P/E Ratio
- MKZR N/A
- FBIO N/A
- Revenue Growth
- MKZR N/A
- FBIO 31.51
- 52 Week Low
- MKZR $1.05
- FBIO $1.36
- 52 Week High
- MKZR $5.50
- FBIO $4.43
- Technical
- Relative Strength Index (RSI)
- MKZR N/A
- FBIO 58.82
- Support Level
- MKZR N/A
- FBIO $1.70
- Resistance Level
- MKZR N/A
- FBIO $2.27
- Average True Range (ATR)
- MKZR 0.00
- FBIO 0.14
- MACD
- MKZR 0.00
- FBIO -0.02
- Stochastic Oscillator
- MKZR 0.00
- FBIO 63.16
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.